$GEG
Great Elm Group, Inc.

2023 Q4 Form 10-Q Financial Statement

#000095017023061230 Filed on November 08, 2023

View on sec.gov

Income Statement

Concept 2023 Q4 2023 Q3
Revenue $2.819M $3.310M
YoY Change 50.03% -82.18%
Cost Of Revenue $2.839M $2.800M
YoY Change 22.85% -66.58%
Gross Profit -$20.00K $500.0K
YoY Change -95.37% -95.1%
Gross Profit Margin -0.71% 15.11%
Selling, General & Admin $2.393M $1.715M
YoY Change 16.11% 15.33%
% of Gross Profit 343.0%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $286.0K $283.0K
YoY Change -114.44% -88.98%
% of Gross Profit 56.6%
Operating Expenses $2.393M $1.715M
YoY Change 16.11% 15.33%
Operating Profit -$2.696M -$1.450M
YoY Change -3.3% 47.21%
Interest Expense $1.061M $1.062M
YoY Change -45.73% -46.79%
% of Operating Profit
Other Income/Expense, Net $0.00
YoY Change -100.0%
Pretax Income -$239.0K $2.758M
YoY Change -100.81% -133.06%
Income Tax $0.00 $0.00
% Of Pretax Income 0.0%
Net Earnings -$350.0K $2.774M
YoY Change -101.19% -133.46%
Net Earnings / Revenue -12.42% 83.81%
Basic Earnings Per Share -$0.01 $0.09
Diluted Earnings Per Share -$0.01 $0.08
COMMON SHARES
Basic Shares Outstanding 31.17M 30.64M
Diluted Shares Outstanding 29.89M 41.86M

Balance Sheet

Concept 2023 Q4 2023 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $122.8M $113.7M
YoY Change 67.08% 77.96%
Cash & Equivalents $39.07M $41.08M
Short-Term Investments $73.69M $72.60M
Other Short-Term Assets $7.979M $6.000M
YoY Change -90.07% 331.34%
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $134.3M $123.8M
YoY Change -14.01% 65.73%
LONG-TERM ASSETS
Property, Plant & Equipment $322.0K $400.0K
YoY Change 600.0% -20.48%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $54.00K $143.0K
YoY Change -62.24% -43.48%
Total Long-Term Assets $11.94M $12.39M
YoY Change -11.7% -85.17%
TOTAL ASSETS
Total Short-Term Assets $134.3M $123.8M
Total Long-Term Assets $11.94M $12.39M
Total Assets $146.2M $136.2M
YoY Change -13.83% -13.92%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $158.0K $200.0K
YoY Change 97.5% -96.85%
Accrued Expenses $4.628M $3.900M
YoY Change 122.82% -47.99%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due $1.154M $1.200M
YoY Change -95.24% -87.56%
Total Short-Term Liabilities $6.884M $5.280M
YoY Change -84.51% -78.65%
LONG-TERM LIABILITIES
Long-Term Debt $64.08M $63.00M
YoY Change 3.67% -33.87%
Other Long-Term Liabilities $611.0K $555.0K
YoY Change 15.94% -43.19%
Total Long-Term Liabilities $611.0K $555.0K
YoY Change 15.94% -43.19%
TOTAL LIABILITIES
Total Short-Term Liabilities $6.884M $5.280M
Total Long-Term Liabilities $611.0K $555.0K
Total Liabilities $71.62M $68.92M
YoY Change -33.44% -44.58%
SHAREHOLDERS EQUITY
Retained Earnings -$3.249B -$3.249B
YoY Change -0.27% -1.18%
Common Stock $30.00K $30.00K
YoY Change 3.45% 3.45%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $67.60M $67.32M
YoY Change
Total Liabilities & Shareholders Equity $146.2M $136.2M
YoY Change -13.83% -13.92%

Cashflow Statement

Concept 2023 Q4 2023 Q3
OPERATING ACTIVITIES
Net Income -$350.0K $2.774M
YoY Change -101.19% -133.46%
Depreciation, Depletion And Amortization $286.0K $283.0K
YoY Change -114.44% -88.98%
Cash From Operating Activities -$13.78M -$6.126M
YoY Change -670.8% -402.67%
INVESTING ACTIVITIES
Capital Expenditures $753.0K
YoY Change 78.86%
Acquisitions
YoY Change
Other Investing Activities $5.625M $118.0K
YoY Change -57.85% -65.19%
Cash From Investing Activities $4.872M -$12.96M
YoY Change -62.3% 471.01%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 6.900M 0.000
YoY Change -137.67% -100.0%
NET CHANGE
Cash From Operating Activities -13.78M -6.126M
Cash From Investing Activities 4.872M -12.96M
Cash From Financing Activities 6.900M 0.000
Net Change In Cash -2.007M -19.09M
YoY Change -32.65% 5684.24%
FREE CASH FLOW
Cash From Operating Activities -$13.78M -$6.126M
Capital Expenditures $753.0K
Free Cash Flow -$14.53M
YoY Change -829.15%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023Q3 dei Amendment Flag
AmendmentFlag
false
CY2023Q3 dei Entity Central Index Key
EntityCentralIndexKey
0001831096
CY2023Q3 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--06-30
CY2023Q3 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2023Q3 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2024
CY2023Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2023Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2023Q3 us-gaap Preferred Stock Value
PreferredStockValue
CY2023Q2 us-gaap Preferred Stock Value
PreferredStockValue
CY2023Q3 us-gaap Fair Value Recurring Basis Unobservable Input Reconciliation Liability Gain Loss Statement Of Income Extensible List
FairValueRecurringBasisUnobservableInputReconciliationLiabilityGainLossStatementOfIncomeExtensibleList
http://www.greatelmgroup.com/20230930#RealizedAndUnrealizedGainLossOnInvestments
CY2022Q3 us-gaap Fair Value Recurring Basis Unobservable Input Reconciliation Liability Gain Loss Statement Of Income Extensible List
FairValueRecurringBasisUnobservableInputReconciliationLiabilityGainLossStatementOfIncomeExtensibleList
http://www.greatelmgroup.com/20230930#RealizedAndUnrealizedGainLossOnInvestments
CY2023Q3 dei Document Type
DocumentType
10-Q
CY2023Q3 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2023Q3 dei Document Period End Date
DocumentPeriodEndDate
2023-09-30
CY2023Q3 dei Document Transition Report
DocumentTransitionReport
false
CY2023Q3 dei Entity File Number
EntityFileNumber
001-39832
CY2023Q3 dei Entity Registrant Name
EntityRegistrantName
Great Elm Group, Inc.
CY2023Q3 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
CY2023Q3 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
85-3622015
CY2023Q3 dei Entity Address Address Line1
EntityAddressAddressLine1
800 South Street
CY2023Q3 dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 230
CY2023Q3 dei Entity Address City Or Town
EntityAddressCityOrTown
Waltham
CY2023Q3 dei Entity Address State Or Province
EntityAddressStateOrProvince
MA
CY2023Q3 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
02453
CY2023Q3 dei City Area Code
CityAreaCode
617
CY2023Q3 dei Local Phone Number
LocalPhoneNumber
375-3006
CY2023Q3 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2023Q3 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2023Q3 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2023Q3 dei Entity Small Business
EntitySmallBusiness
true
CY2023Q3 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2023Q3 dei Entity Shell Company
EntityShellCompany
false
CY2023Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
31174605
CY2023Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
41077000
CY2023Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
60165000
CY2023Q3 geg Investments In Marketable Securities
InvestmentsInMarketableSecurities
34783000
CY2023Q2 geg Investments In Marketable Securities
InvestmentsInMarketableSecurities
24595000
CY2023Q3 geg Investments Cost Basis
InvestmentsCostBasis
44158000
CY2023Q2 geg Investments Cost Basis
InvestmentsCostBasis
40387000
CY2023Q3 us-gaap Investments
Investments
37865000
CY2023Q2 us-gaap Investments
Investments
32611000
CY2023Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
2935000
CY2023Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
717000
CY2023Q3 us-gaap Real Estate Held For Development And Sale
RealEstateHeldForDevelopmentAndSale
3116000
CY2023Q2 us-gaap Real Estate Held For Development And Sale
RealEstateHeldForDevelopmentAndSale
1742000
CY2023Q3 us-gaap Assets Current
AssetsCurrent
123849000
CY2023Q2 us-gaap Assets Current
AssetsCurrent
123138000
CY2023Q3 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
11839000
CY2023Q2 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
12115000
CY2023Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
411000
CY2023Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
497000
CY2023Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
143000
CY2023Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
143000
CY2023Q3 us-gaap Assets
Assets
136242000
CY2023Q2 us-gaap Assets
Assets
135893000
CY2023Q3 us-gaap Accrued Liabilities And Other Liabilities
AccruedLiabilitiesAndOtherLiabilities
3514000
CY2023Q2 us-gaap Accrued Liabilities And Other Liabilities
AccruedLiabilitiesAndOtherLiabilities
5418000
CY2023Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
356000
CY2023Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
359000
CY2023Q3 us-gaap Liabilities Current
LiabilitiesCurrent
5280000
CY2023Q2 us-gaap Liabilities Current
LiabilitiesCurrent
7377000
CY2023Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
50000
CY2023Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
142000
CY2023Q3 us-gaap Long Term Debt Fair Value
LongTermDebtFairValue
26945000
CY2023Q2 us-gaap Long Term Debt Fair Value
LongTermDebtFairValue
26945000
CY2023Q3 us-gaap Other Long Term Debt Noncurrent
OtherLongTermDebtNoncurrent
25878000
CY2023Q2 us-gaap Other Long Term Debt Noncurrent
OtherLongTermDebtNoncurrent
25808000
CY2023Q3 us-gaap Debt Instrument Face Amount
DebtInstrumentFaceAmount
37912000
CY2023Q2 us-gaap Debt Instrument Face Amount
DebtInstrumentFaceAmount
37912000
CY2023Q3 geg Convertible Notes Payable Held By Related Party Non Current
ConvertibleNotesPayableHeldByRelatedPartyNonCurrent
15395000
CY2023Q2 geg Convertible Notes Payable Held By Related Party Non Current
ConvertibleNotesPayableHeldByRelatedPartyNonCurrent
15395000
CY2023Q3 us-gaap Convertible Debt Noncurrent
ConvertibleDebtNoncurrent
37158000
CY2023Q2 us-gaap Convertible Debt Noncurrent
ConvertibleDebtNoncurrent
37129000
CY2023Q3 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
555000
CY2023Q2 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
669000
CY2023Q3 us-gaap Liabilities
Liabilities
68921000
CY2023Q2 us-gaap Liabilities
Liabilities
72051000
CY2023Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2023Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2023Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000
CY2023Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000
CY2023Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2023Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2023Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2023Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2023Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
350000000
CY2023Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
350000000
CY2023Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
31174605
CY2023Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
29868909
CY2023Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
30651047
CY2023Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
29546655
CY2023Q3 us-gaap Common Stock Value
CommonStockValue
30000
CY2023Q2 us-gaap Common Stock Value
CommonStockValue
30000
CY2023Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
3316083000
CY2023Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
3315378000
CY2023Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-3248792000
CY2023Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-3251566000
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
67321000
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
63842000
CY2023Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
136242000
CY2023Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
135893000
CY2023Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
3310000
CY2022Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1860000
CY2023Q3 us-gaap Management Fee Expense
ManagementFeeExpense
2762000
CY2022Q3 us-gaap Management Fee Expense
ManagementFeeExpense
1989000
CY2023Q3 us-gaap Depreciation And Amortization
DepreciationAndAmortization
283000
CY2022Q3 us-gaap Depreciation And Amortization
DepreciationAndAmortization
294000
CY2023Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
1715000
CY2022Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
1487000
CY2022Q3 geg Expenses Of Consolidated Funds
ExpensesOfConsolidatedFunds
46000
CY2023Q3 us-gaap Costs And Expenses
CostsAndExpenses
4760000
CY2022Q3 us-gaap Costs And Expenses
CostsAndExpenses
3816000
CY2023Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-1450000
CY2022Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-1956000
CY2023Q3 us-gaap Investment Income Interest And Dividend
InvestmentIncomeInterestAndDividend
1986000
CY2022Q3 us-gaap Investment Income Interest And Dividend
InvestmentIncomeInterestAndDividend
1473000
CY2023Q3 geg Realized And Unrealized Gain Loss On Investments
RealizedAndUnrealizedGainLossOnInvestments
3284000
CY2022Q3 geg Realized And Unrealized Gain Loss On Investments
RealizedAndUnrealizedGainLossOnInvestments
-6797000
CY2022Q3 geg Net Realized And Unrealized Gain On Investments Of Consolidated Funds
NetRealizedAndUnrealizedGainOnInvestmentsOfConsolidatedFunds
-16000
CY2023Q3 us-gaap Interest Expense
InterestExpense
1062000
CY2022Q3 us-gaap Interest Expense
InterestExpense
1974000
CY2023Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
2758000
CY2022Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-9270000
CY2022Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
233000
CY2023Q3 us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
2758000
CY2022Q3 us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
-9503000
CY2023Q3 us-gaap Discontinued Operation Income Loss From Discontinued Operation During Phase Out Period Net Of Tax
DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodNetOfTax
16000
CY2022Q3 us-gaap Discontinued Operation Income Loss From Discontinued Operation During Phase Out Period Net Of Tax
DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodNetOfTax
964000
CY2023Q3 us-gaap Profit Loss
ProfitLoss
2774000
CY2022Q3 us-gaap Profit Loss
ProfitLoss
-8539000
CY2022Q3 us-gaap Income Loss From Continuing Operations Attributable To Noncontrolling Entity
IncomeLossFromContinuingOperationsAttributableToNoncontrollingEntity
-1572000
CY2022Q3 us-gaap Income Loss From Discontinued Operations Net Of Tax Attributable To Noncontrolling Interest
IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToNoncontrollingInterest
1324000
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
2774000
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-8291000
CY2023Q3 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
0.09
CY2022Q3 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
-0.28
CY2022Q3 us-gaap Income Loss From Discontinued Operations Net Of Tax Per Basic Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
-0.01
CY2023Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.09
CY2022Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.29
CY2023Q3 us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
0.08
CY2022Q3 us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
-0.28
CY2022Q3 us-gaap Income Loss From Discontinued Operations Net Of Tax Per Diluted Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
-0.01
CY2023Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.08
CY2022Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.29
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
29579000
CY2022Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
28543000
CY2023Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
41860000
CY2022Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
28543000
CY2023Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
63842000
CY2023Q3 us-gaap Net Income Loss Including Portion Attributable To Nonredeemable Noncontrolling Interest
NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest
2774000
CY2023Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
705000
CY2023Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
67321000
CY2022Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
40029000
CY2022Q2 us-gaap Redeemable Noncontrolling Interest Equity Carrying Amount
RedeemableNoncontrollingInterestEquityCarryingAmount
2225000
CY2022Q3 us-gaap Net Income Loss Including Portion Attributable To Nonredeemable Noncontrolling Interest
NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest
-9201000
CY2022Q3 us-gaap Net Income Loss Attributable To Redeemable Noncontrolling Interest
NetIncomeLossAttributableToRedeemableNoncontrollingInterest
662000
CY2022Q3 geg Distributions To Non Controlling Interests In Consolidated Fund
DistributionsToNonControllingInterestsInConsolidatedFund
634000
CY2022Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
834000
CY2022Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
31028000
CY2022Q3 us-gaap Redeemable Noncontrolling Interest Equity Carrying Amount
RedeemableNoncontrollingInterestEquityCarryingAmount
2887000
CY2023Q3 us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
2758000
CY2022Q3 us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
-9503000
CY2023Q3 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
283000
CY2022Q3 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
294000
CY2023Q3 us-gaap Share Based Compensation
ShareBasedCompensation
705000
CY2022Q3 us-gaap Share Based Compensation
ShareBasedCompensation
834000
CY2022Q3 geg Sales Of Investments By Consolidated Funds
SalesOfInvestmentsByConsolidatedFunds
1558000
CY2022Q3 geg Realized Gain Loss On Investments From Consolidated Funds
RealizedGainLossOnInvestmentsFromConsolidatedFunds
-16000
CY2023Q3 geg Unrealized Gain Loss On Investments Including Investments Of Consolidated Fund
UnrealizedGainLossOnInvestmentsIncludingInvestmentsOfConsolidatedFund
3372000
CY2022Q3 geg Unrealized Gain Loss On Investments Including Investments Of Consolidated Fund
UnrealizedGainLossOnInvestmentsIncludingInvestmentsOfConsolidatedFund
-1182000
CY2023Q3 us-gaap Realized Investment Gains Losses
RealizedInvestmentGainsLosses
-88000
CY2022Q3 us-gaap Realized Investment Gains Losses
RealizedInvestmentGainsLosses
-5615000
CY2023Q3 geg Non Cash Interest And Amortization Of Capitalized Issuance Costs
NonCashInterestAndAmortizationOfCapitalizedIssuanceCosts
573000
CY2023Q3 us-gaap Interest Paid Net
InterestPaidNet
488000
CY2022Q3 us-gaap Interest Paid Net
InterestPaidNet
1345000
CY2022Q3 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
167000
CY2022Q3 geg Partial Settlement Of Note In Exchange For Stock
PartialSettlementOfNoteInExchangeForStock
-609000
CY2022Q3 geg Non Cash Distributions Received From Consolidated Fund
NonCashDistributionsReceivedFromConsolidatedFund
177000
CY2022Q3 geg Non Cash Interest And Amortization Of Capitalized Issuance Costs
NonCashInterestAndAmortizationOfCapitalizedIssuanceCosts
128000
CY2023Q3 us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
18000
CY2022Q3 us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
-70000
CY2023Q3 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
207000
CY2022Q3 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-158000
CY2023Q3 us-gaap Increase Decrease In Accounts Receivable Related Parties
IncreaseDecreaseInAccountsReceivableRelatedParties
765000
CY2022Q3 us-gaap Increase Decrease In Accounts Receivable Related Parties
IncreaseDecreaseInAccountsReceivableRelatedParties
133000
CY2023Q3 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
2218000
CY2022Q3 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-401000
CY2023Q3 geg Increase Decrease In Real Estate Under Development
IncreaseDecreaseInRealEstateUnderDevelopment
-1408000
CY2023Q3 us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-8000
CY2022Q3 us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-1000
CY2023Q3 us-gaap Increase Decrease In Accounts Payable Related Parties
IncreaseDecreaseInAccountsPayableRelatedParties
-1125000
CY2022Q3 us-gaap Increase Decrease In Accounts Payable Related Parties
IncreaseDecreaseInAccountsPayableRelatedParties
-413000
CY2023Q3 geg Increase Decrease In Accounts Payable Accrued Liabilities And Other Liabilities
IncreaseDecreaseInAccountsPayableAccruedLiabilitiesAndOtherLiabilities
-1448000
CY2022Q3 geg Increase Decrease In Accounts Payable Accrued Liabilities And Other Liabilities
IncreaseDecreaseInAccountsPayableAccruedLiabilitiesAndOtherLiabilities
-847000
CY2023Q3 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-6126000
CY2022Q3 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-781000
CY2022Q3 us-gaap Cash Provided By Used In Operating Activities Discontinued Operations
CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations
2805000
CY2023Q3 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-6126000
CY2022Q3 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
2024000
CY2023Q3 us-gaap Payments To Acquire Held To Maturity Securities
PaymentsToAcquireHeldToMaturitySecurities
9801000
CY2023Q3 us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
4476000
CY2023Q3 us-gaap Proceeds From Sale Of Short Term Investments
ProceedsFromSaleOfShortTermInvestments
1793000
CY2023Q3 us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
118000
CY2022Q3 us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
11000
CY2023Q3 us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-12602000
CY2022Q3 us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-11000
CY2023Q3 us-gaap Cash Provided By Used In Investing Activities Discontinued Operations
CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations
-360000
CY2022Q3 us-gaap Cash Provided By Used In Investing Activities Discontinued Operations
CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations
-2259000
CY2023Q3 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-12962000
CY2022Q3 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-2270000
CY2022Q3 geg Distributions To Non Controlling Interests In Consolidated Funds
DistributionsToNonControllingInterestsInConsolidatedFunds
-634000
CY2022Q3 us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
-634000
CY2022Q3 us-gaap Cash Provided By Used In Financing Activities Discontinued Operations
CashProvidedByUsedInFinancingActivitiesDiscontinuedOperations
550000
CY2022Q3 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-84000
CY2023Q3 geg Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Cash And Cash Equivalents Classified Within Current Assets Held For Sale
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingCashAndCashEquivalentsClassifiedWithinCurrentAssetsHeldForSale
-19088000
CY2022Q3 geg Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Cash And Cash Equivalents Classified Within Current Assets Held For Sale
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingCashAndCashEquivalentsClassifiedWithinCurrentAssetsHeldForSale
-330000
CY2022Q3 geg Cash Cash Equivalents Period Increase Decrease Classified Within Current Assets Held For Sale
CashCashEquivalentsPeriodIncreaseDecreaseClassifiedWithinCurrentAssetsHeldForSale
1096000
CY2022Q3 geg Discontinued Operation Amount Of Continuing Cash Flows
DiscontinuedOperationAmountOfContinuingCashFlows
1694000
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-19088000
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
268000
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
60165000
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
22281000
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
41077000
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
22549000
CY2023Q3 us-gaap Use Of Estimates
UseOfEstimates
<p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Use of Estimates</span></p><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The preparation of these financial statements in accordance with accounting principles generally accepted in the United States of America (</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">US GAAP</span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">) requires the Company to make estimates and assumptions that affect the reported amounts of assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the periods presented. On an on-going basis, the Company evaluates all of these estimates and assumptions. The most important of these estimates and assumptions relate to revenue recognition, valuation allowance for deferred tax assets, estimates associated with accounting for asset acquisitions, and fair value measurements, including stock-based compensation. </span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Although these and other estimates and assumptions are based on the best available information, actual results could be different from these estimates.</span></p>
CY2023Q3 us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
2758000
CY2022Q3 us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
-9503000
CY2022Q3 us-gaap Income Loss From Continuing Operations Attributable To Noncontrolling Entity
IncomeLossFromContinuingOperationsAttributableToNoncontrollingEntity
-1572000
CY2023Q3 us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
2758000
CY2022Q3 us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
-7931000
CY2023Q3 us-gaap Income Loss From Discontinued Operations Net Of Tax
IncomeLossFromDiscontinuedOperationsNetOfTax
16000
CY2022Q3 us-gaap Income Loss From Discontinued Operations Net Of Tax
IncomeLossFromDiscontinuedOperationsNetOfTax
964000
CY2022Q3 us-gaap Income Loss From Discontinued Operations Net Of Tax Attributable To Noncontrolling Interest
IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToNoncontrollingInterest
1324000
CY2023Q3 us-gaap Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity
IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity
16000
CY2022Q3 us-gaap Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity
IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity
-360000
CY2023Q3 us-gaap Interest On Convertible Debt Net Of Tax
InterestOnConvertibleDebtNetOfTax
503000
CY2023Q3 us-gaap Net Income Loss From Continuing Operations Available To Common Shareholders Diluted
NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersDiluted
3261000
CY2022Q3 us-gaap Net Income Loss From Continuing Operations Available To Common Shareholders Diluted
NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersDiluted
-7931000
CY2023Q3 us-gaap Net Income Loss From Discontinued Operations Available To Common Shareholders Diluted
NetIncomeLossFromDiscontinuedOperationsAvailableToCommonShareholdersDiluted
16000
CY2022Q3 us-gaap Net Income Loss From Discontinued Operations Available To Common Shareholders Diluted
NetIncomeLossFromDiscontinuedOperationsAvailableToCommonShareholdersDiluted
-360000
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
29579000
CY2022Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
28543000
CY2023Q3 geg Incremental Common Shares Attributable To Restricted Stock
IncrementalCommonSharesAttributableToRestrictedStock
1363000
CY2023Q3 us-gaap Incremental Common Shares Attributable To Conversion Of Debt Securities
IncrementalCommonSharesAttributableToConversionOfDebtSecurities
10918000
CY2023Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
41860000
CY2022Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
28543000
CY2023Q3 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
0.09
CY2022Q3 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
-0.28
CY2022Q3 us-gaap Income Loss From Discontinued Operations Net Of Tax Per Basic Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
-0.01
CY2023Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.09
CY2022Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.29
CY2023Q3 us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
0.08
CY2022Q3 us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
-0.28
CY2022Q3 us-gaap Income Loss From Discontinued Operations Net Of Tax Per Diluted Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
-0.01
CY2023Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.08
CY2022Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.29
CY2023Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
3264424
CY2023Q3 us-gaap Weighted Average Number Of Shares Common Stock Subject To Repurchase Or Cancellation
WeightedAverageNumberOfSharesCommonStockSubjectToRepurchaseOrCancellation
1362723
CY2022Q3 us-gaap Weighted Average Number Of Shares Common Stock Subject To Repurchase Or Cancellation
WeightedAverageNumberOfSharesCommonStockSubjectToRepurchaseOrCancellation
1303386
CY2023Q3 us-gaap Change In Accounting Principle Accounting Standards Update Adopted
ChangeInAccountingPrincipleAccountingStandardsUpdateAdopted
true
CY2023Q3 us-gaap Change In Accounting Principle Accounting Standards Update Adoption Date
ChangeInAccountingPrincipleAccountingStandardsUpdateAdoptionDate
2023-07-01
CY2023Q3 us-gaap Change In Accounting Principle Accounting Standards Update Immaterial Effect
ChangeInAccountingPrincipleAccountingStandardsUpdateImmaterialEffect
true
CY2023Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
3310000
CY2022Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1860000
CY2023Q3 geg Incentive Fee Earned As Percentage On Investment Performance
IncentiveFeeEarnedAsPercentageOnInvestmentPerformance
0.20
CY2023Q3 geg Accrued Incentive Fee Earned Based On Investment Performance
AccruedIncentiveFeeEarnedBasedOnInvestmentPerformance
1300000
CY2023Q3 geg Consolidated Funds
ConsolidatedFunds
0
CY2023Q3 geg Fair Value Liabilities Level2 To Level1 Transfer Amount
FairValueLiabilitiesLevel2ToLevel1TransferAmount
0
CY2023Q3 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
37865000
CY2023Q3 us-gaap Business Combination Contingent Consideration Liability Current
BusinessCombinationContingentConsiderationLiabilityCurrent
944000
CY2023Q3 us-gaap Liabilities Fair Value Disclosure
LiabilitiesFairValueDisclosure
944000
CY2023Q2 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
32611000
CY2023Q2 us-gaap Business Combination Contingent Consideration Liability Current
BusinessCombinationContingentConsiderationLiabilityCurrent
1903000
CY2023Q2 us-gaap Liabilities Fair Value Disclosure
LiabilitiesFairValueDisclosure
1903000
CY2023Q3 geg Fair Value Assets Level1 To Level2 Transfer Amount
FairValueAssetsLevel1ToLevel2TransferAmount
0
CY2022Q3 geg Fair Value Assets Level1 To Level2 Transfer Amount
FairValueAssetsLevel1ToLevel2TransferAmount
0
CY2023Q3 geg Fair Value Assets Level2 To Level1 Transfer Amount
FairValueAssetsLevel2ToLevel1TransferAmount
0
CY2022Q3 geg Fair Value Assets Level2 To Level1 Transfer Amount
FairValueAssetsLevel2ToLevel1TransferAmount
0
CY2023Q3 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Transfers Into Level3
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3
0
CY2022Q3 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Transfers Into Level3
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3
0
CY2023Q3 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Transfers Out Of Level3
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3
0
CY2022Q3 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Transfers Out Of Level3
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3
0
CY2023Q3 geg Fair Value Liabilities Level1 To Level2 Transfer Amount
FairValueLiabilitiesLevel1ToLevel2TransferAmount
0
CY2022Q3 geg Fair Value Liabilities Level1 To Level2 Transfer Amount
FairValueLiabilitiesLevel1ToLevel2TransferAmount
0
CY2022Q3 geg Fair Value Liabilities Level2 To Level1 Transfer Amount
FairValueLiabilitiesLevel2ToLevel1TransferAmount
0
CY2023Q3 geg Fair Value Liabilities Level2 To Level1 Transfer Amount
FairValueLiabilitiesLevel2ToLevel1TransferAmount
0
CY2023Q2 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
1903000
CY2022Q2 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
1120000
CY2023Q3 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Sales
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySales
977000
CY2023Q3 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Earnings
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings
18000
CY2022Q3 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Earnings
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings
-70000
CY2023Q3 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
944000
CY2022Q3 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
1050000
CY2023Q3 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Liability Transfers Into Level3
FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersIntoLevel3
0
CY2022Q3 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Liability Transfers Into Level3
FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersIntoLevel3
0
CY2023Q3 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Liability Transfers Out Of Level3
FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersOutOfLevel3
0
CY2022Q3 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Liability Transfers Out Of Level3
FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersOutOfLevel3
0
CY2023Q3 geg Notice Period For Annually Allowable Redemptions
NoticePeriodForAnnuallyAllowableRedemptions
P90D
CY2023Q3 geg Lockup Period From Date Of Investment
LockupPeriodFromDateOfInvestment
P1Y
CY2023Q3 geg Fair Value Investment Capped Percentage Of Net Asset Value
FairValueInvestmentCappedPercentageOfNetAssetValue
0.05
CY2023Q3 geg Capitalized Cost Within Real Estate Under Development Current
CapitalizedCostWithinRealEstateUnderDevelopmentCurrent
1400000
CY2023Q3 geg Number Of Identifiable Real Estate Projects
NumberOfIdentifiableRealEstateProjects
2
CY2023Q3 us-gaap Interest Expense Other
InterestExpenseOther
600000
CY2022Q3 us-gaap Interest Expense Other
InterestExpenseOther
700000
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
3264000
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
2.7
CY2023 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P7Y5M12D
CY2023Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
3264000
CY2023Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
2.7
CY2023Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P7Y2M12D
CY2023Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
1260000
CY2023Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
3.72
CY2023Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P3Y4M17D
CY2023Q2 us-gaap Deferred Tax Assets Operating Loss Carryforwards Domestic
DeferredTaxAssetsOperatingLossCarryforwardsDomestic
16200000

Files In Submission

Name View Source Status
FilingSummary.xml Edgar Link unprocessable
0000950170-23-061230-index-headers.html Edgar Link pending
0000950170-23-061230-index.html Edgar Link pending
0000950170-23-061230.txt Edgar Link pending
0000950170-23-061230-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
geg-20230930.htm Edgar Link pending
geg-20230930.xsd Edgar Link pending
geg-ex31_1.htm Edgar Link pending
geg-ex31_2.htm Edgar Link pending
geg-ex32_1.htm Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
geg-20230930_cal.xml Edgar Link unprocessable
geg-20230930_def.xml Edgar Link unprocessable
geg-20230930_lab.xml Edgar Link unprocessable
geg-20230930_pre.xml Edgar Link unprocessable
geg-20230930_htm.xml Edgar Link completed
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending